Torii Pharmaceutical Co Ltd
TSE:4551
Torii Pharmaceutical Co Ltd
Gross Profit
Torii Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Torii Pharmaceutical Co Ltd
TSE:4551
|
Gross Profit
¥26.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Gross Profit
¥3T
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Gross Profit
¥1.4T
|
CAGR 3-Years
26%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Gross Profit
¥1.7T
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Gross Profit
¥831.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Gross Profit
¥1.5T
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
|
Torii Pharmaceutical Co Ltd
Glance View
Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.
See Also
What is Torii Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
26.7B
JPY
Based on the financial report for Dec 31, 2024, Torii Pharmaceutical Co Ltd's Gross Profit amounts to 26.7B JPY.
What is Torii Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
-1%
Over the last year, the Gross Profit growth was 8%. The average annual Gross Profit growth rates for Torii Pharmaceutical Co Ltd have been 3% over the past three years , 4% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet